FR3797M - Nouvelle préparation pharmaceutique pour le traitement du diabetes mellitus. - Google Patents

Nouvelle préparation pharmaceutique pour le traitement du diabetes mellitus.

Info

Publication number
FR3797M
FR3797M FR993173A FR993173A FR3797M FR 3797 M FR3797 M FR 3797M FR 993173 A FR993173 A FR 993173A FR 993173 A FR993173 A FR 993173A FR 3797 M FR3797 M FR 3797M
Authority
FR
France
Prior art keywords
treatment
diabetes mellitus
pharmaceutical preparation
new pharmaceutical
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR993173A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of FR3797M publication Critical patent/FR3797M/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • C07D231/42Benzene-sulfonamido pyrazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44Oxygen and nitrogen or sulfur and nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR993173A 1963-11-05 1964-10-29 Nouvelle préparation pharmaceutique pour le traitement du diabetes mellitus. Expired FR3797M (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1359863 1963-11-05
CH1210364 1964-09-17

Publications (1)

Publication Number Publication Date
FR3797M true FR3797M (fr) 1965-12-27

Family

ID=25709624

Family Applications (2)

Application Number Title Priority Date Filing Date
FR993173A Expired FR3797M (fr) 1963-11-05 1964-10-29 Nouvelle préparation pharmaceutique pour le traitement du diabetes mellitus.
FR993172A Expired FR4034M (enExample) 1963-11-05 1965-10-29

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR993172A Expired FR4034M (enExample) 1963-11-05 1965-10-29

Country Status (5)

Country Link
BE (1) BE655242A (enExample)
DE (1) DE1467832A1 (enExample)
FR (2) FR3797M (enExample)
GB (1) GB1054278A (enExample)
NL (1) NL6412822A (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3503609A1 (de) * 1985-02-02 1986-08-07 Bayer Ag, 5090 Leverkusen 5-sulfonamido-1-aryl-pyrazole
WO2013046041A1 (en) 2011-09-30 2013-04-04 Synovo Gmbh Pyridinylpyrazoles for use as kinase modulators for the treatment of cancer
JP6263553B2 (ja) 2013-01-17 2018-01-17 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Cns疾患の処置のためのオキシトシン受容体アゴニスト
RU2579515C1 (ru) * 2014-12-29 2016-04-10 Федеральное государственное бюджетное образовательное учреждение высшего образования "Сибирский государственный технологический университет" (СибГТУ) Алкоксиметилзамещенные 1н-4-аминопиразолы

Also Published As

Publication number Publication date
GB1054278A (en) 1967-01-11
FR4034M (enExample) 1966-03-28
NL6412822A (enExample) 1965-05-06
BE655242A (enExample) 1965-05-04
DE1467832A1 (de) 1968-11-28

Similar Documents

Publication Publication Date Title
FR3384M (fr) Nouvelle composition pour aérosols pharmaceutiques.
CH443268A (fr) Procédé pour la préparation de nouvelles pseudo-ionones
FR3010M (fr) Nouveaux médicaments dérivés du benzene pour le traitement des maladies cardiaques.
FR3797M (fr) Nouvelle préparation pharmaceutique pour le traitement du diabetes mellitus.
FR2489M (fr) Médicament pour le traitement de la dysenterie amibienne.
OA00939A (fr) Procédé pour la préparation d'amino-isoxazoles.
FR1463838A (fr) Procédé pour la préparation de nouvelles benzènesulfonylurées
FR2193M (fr) Nouveau médicament pour le traitement des maladies infectieuses.
FR3066M (fr) Nouveau médicament notamment pour le traitement de l'hyperlipémie post-prandiale ou chronique.
BE812974A (fr) Compositions pharmaceutiques pour le traitement des ulceres
FR1338926A (fr) Four pour le traitement de feuillards
FR2929M (fr) Composition pharmaceutique pour le traitement des affections arthritiques et rhumatismales.
FR2817M (fr) Associations de médicaments pour le traitement des désordres mentaux.
FR2346M (fr) Médicament pour le traitement des colopathies.
FR2684M (fr) Composition pharmaceutique pour le traitement local des douleurs rhumatismales.
BE650350A (fr) Composition pour le traitement de la goutte
BE772424A (fr) Composition dermo-pharmaceutique pour le traitement des affections seborreheiques
FR1424566A (fr) Nouveaux comprimés pour la préparation de bains de traitement photographique
FR2965M (fr) Préparation thérapeutique pour le traitement des syndromes anginaux.
FR1911M (fr) Nouveau médicament pour le traitement des troubles du systeme circulatoire.
FR2536M (fr) Nouvelle composition pour le traitement de la bilharziose.
BE792933A (fr) Medicament pour le traitement du syndrome hypercinetique
FR3744M (fr) Médicaments pour le traitement des affections psychiatriques.
FR3569M (fr) Composition thérapeutique pour la correction du dysmicrobisme intestinal.
FR2323M (fr) Nouveau médicament notamment pour le traitement de l'hyperactivité folliculostimulante.